Aberrant DNA methylation of G-protein-coupled bile acid receptor gpbar1 (TGR5) is a potential biomarker for hepatitis B virus associated hepatocellular carcinoma

International Journal of Medical Sciences

Volumn 11, Issue 2, 2014, Pages 164-171

  Han, Li Yan ^a,b   Fan, Yu Chen ^a,b   Mu, Nan Nan ^c   Gao, Shuai ^a   Li, Feng ^a   Ji, Xiang Fen ^a   Dou, Cheng Yun ^a   Wang, Kai ^a,b  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

^c General Hospital Jinan Military   (China)

Author keywords

DNA methylation; Hepatocellular carcinoma; MSP; Serum; TGR5

Indexed keywords

ALPHA FETOPROTEIN;

ADULT; AGE; ARTICLE; CANCER SCREENING; CONTROLLED STUDY; DIAGNOSTIC VALUE; DNA METHYLATION; FEMALE; HEPATITIS B; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PROMOTER REGION; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; TGR5 GENE; TUMOR SUPPRESSOR GENE; YOUDEN INDEX;

DNA METHYLATION; HEPATOCELLULAR CARCINOMA; MSP; SERUM; TGR5;

ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; DNA METHYLATION; FEMALE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROMOTER REGIONS, GENETIC; RECEPTORS, G-PROTEIN-COUPLED; TUMOR MARKERS, BIOLOGICAL;

EID: 84892188509     PISSN: 14491907     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijms.6745     Document Type: Article

References (39)

1. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin. 2011; 61: 69-90
2. Perz JF, Armstrong GL, Farrington LA, et al. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol. 2006; 45: 529-538
3. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet. 2003; 362: 1907-1917
4. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med. 1999; 340: 745-750
5. Deuffic S, Poynard T, Buffat L, et al. Trends in primary liver cancer. Lancet. 1998; 351: 214-215
6. El-Serag HB, Marrero JA, Rudolph L, et al. Diagnosis and treatment of hepatocellular carcinoma. Gastroenterology. 2008; 134: 1752-1763
7. Cokus SJ, Feng S, Zhang X, et al. Shotgun bisulphite sequencing of the Arabidopsis genome reveals DNA methylation patterning. Nature. 2008; 452: 215-219
8. Oshimo Y, Nakayama H, Ito R, et al. Promoter methylation of cyclin D2 gene in gastric carcinoma. Int J Oncol. 2003; 23: 1663-1670
9. Baylin SB, Ohm JE. Epigenetic gene silencing in cancer-a mechanism for early oncogenic pathway addiction? Nat Rev Cancer. 2006; 6: 107-116
10. Chan TA, Baylin SB. Epigenetic biomarkers. Curr Top Microbiol Immunol. 2012; 355: 189-216
11. Sun FK, Fan YC, Zhao J, et al. Detection of TFPI2 Methylation in the Serum of Hepatocellular Carcinoma Patients. Dig Dis Sci 2012; [Epub ahead of print]
12. Huang ZH, Hu Y, Hua D, et al. Quantitative analysis of multiple methylated genes in plasma for the diagnosis and prognosis of hepatocellular carcinoma. Exp MolPathol. 2011; 91: 702-707
13. Zhang YJ, Wu HC, Shen J, et al. Predicting hepatocellular carcinoma by detection of aberrant promoter methylation in serum DNA. Clin Cancer Res. 2007; 13: 2378-2384
14. Wang J, Qin Y, Li B, et al. Detection of aberrant promoter methylation of GSTP1 in the tumor and serum of Chinese human primary hepatocellular carcinoma patients. Clin Biochem. 2006; 39: 344-348
15. Watanabe M, Houten SM, Mataki C, et al. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature. 2006; 439: 484-489
16. Maruyama T, Tanaka K, Suzuki J, et al. Targeted disruption of G protein- coupled bile acid receptor 1 (Gpbar1/M-Bar) in mice. J Endocrinol. 2006; 191: 197-205
17. Thomas C, Gioiello A, Noriega L, et al. TGR5-mediated bile acid sensing controls glucose homeostasis. Cell Metab. 2009; 10: 167-177
18. Wang YD, Chen WD, Yu D, et al. The G-protein-coupled bile acid receptor, Gpbar1 (TGR5), negatively regulates hepatic inflammatory response through antagonizing nuclear factor κ light-chain enhancer of activated B cells (NF-κB) in mice. Hepatology. 2011; 54: 1421-32
19. Chen WD, Yu D, Forman BM, et al. Deficiency of G-protein-coupled bile acid receptor Gpbar1 (TGR5) enhances chemically induced liver carcinogenesis. Hepatology. 2013; 57: 656-66
20. Akizu N, Estarás C, Guerrero L, et al. H3K27me3 regulates BMP activity in developing spinal cord. Development. 2010;137:2915-25
21. Li C, Chu N, Wang B, et al. Polymorphisms in the presumptive promoter region of the SLC2A9 gene are associated with gout in a Chinese male population. PLoS One. 2012;7:e24561
22. Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology. 2011; 53: 1020-1022
23. Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology. 2009; 50: 661-662
24. Li LC and Dahiya R. MethPrimer: designing primers for methylation PCRs. Bioinformatics. 2002;18:1427-31
25. Schafer DF, Sorrell MF. Hepatocellular carcinoma. Lancet. 1999; 353: 1253-7
26. De Masi S, Tosti ME, Mele A. Screening for hepatocellular carcinoma. Dig Liver Dis. 2005; 37: 260-8
27. Li X, Hui AM, Sun L, et al. p16INK4A hypermethylation is associated with hepatitis virus infection, age, and gender in hepatocellular carcinoma. Clin Cancer Res. 2004; 10: 7484-9
28. Ahuja N, Li Q, Mohan AL, et al. Aging and DNA methylation in colorectal mucosa and cancer. Cancer Res. 1998; 58: 5489-94
29. Tsutsui M, Iizuka N, Moribe T, et al. Methylated cyclin D2 gene circulating in the blood as a prognosis predictor of hepatocellular carcinoma. Clin Chim Acta. 2010; 411: 516-20
30. Beasley RP, Hwang LY, Lin CC, et al. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet. 1981; 2: 1129-1133
31. Jordi Bruix, Morris Sherman. Management of Hepatocellular Carcinoma. Hepatology. 2005; 42: 1208-36
32. Irizarry RA, Ladd-Acosta C, Wen B, et al. The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat Genet. 2009;41:178-186
33. Doi A, Park IH, Wen B, et al. Differential methylation of tissue- and cancer- specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts. Nat Genet. 2009;41:1350-1353
34. Ji H, Ehrlich LI, Seita J, et al. Comprehensive methylome map of lineage commitment from haematopoietic progenitors. Nature. 2010;467:338-342
35. Futscher BW, Oshiro MM, Wozniak RJ, et al. Role for DNA methylation in the control of cell type specific maspin expression. Nat Genet. 2002;31:175-179
36. Liu L, Kron KJ, Pethe VV, et al. Association of tissue promoter methylation levels of APC, TGFbeta2, HOXD3 and RASSF1A with prostate cancer progression. Int J Cancer. 2011;129:2454-2462
37. Takamaru H, Yamamoto E, Suzuki H, et al. Aberrant methylation of RASGRF1 is associated with an epigenetic field defect and increased risk of gastric cancer. Cancer Prev Res. 2012;5:1203-12
38. Lambert MP, Paliwal A, Vaissière T, et al. Aberrant DNA methylation distinguishes hepatocellular carcinoma associated with HBV and HCV infection and alcohol intake. J Hepatol. 2011;54:705-15
39. Sandoval J, Esteller M. Cancer epigenomics: beyond genomics. Curr Opin Genet Dev. 2012;22:50-5.